Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Snow Ellen. Director active across 2 companies, notably Pear Therapeutics, Inc.. Aggregated, 4 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €8k. History available since 14 January 2023. The latest transaction was filed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Snow Ellen is a declarant linked to Akebia Therapeutics, Inc., where the listed role is SVP, CFO and Treasurer, and to Pear Therapeutics, Inc., where the listed role is Chief Accounting Officer. They have 4 filings in total, with 0 in buys and 8372 in sales across the recent filings tracked, from 2023-01-18 to 2024-02-02; the modal transaction nature is Attribution.